-3x Short ARK (SARKK) | Stock Overview & Key Data
-3x Short ARK Innovation ETP | Micro-cap
-3x Short ARK Innovation ETP | Micro-cap
-3x Short ARK Performance Comparison
Stock Range
Today's Range
Low: €12.75
High: €12.83
on September 23, 2025
52 Week Range
Low: €0.03
High: €25.70
on July 7, 2025
on July 8, 2025
All-Time High: €25.70 on July 8, 2025
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Market Cap
N/A
EPS
0.03
P/E Ratio (TTM)
497.20
Forward P/E
N/A
P/B Ratio
3.67
PEG Ratio
0.33
Div. Yield
N/A
ROE
1.11%
Beta
N/A
Debt to Equity
0.03
Financial Highlights
Profitability
Gross Margin
28.04%
Operating Margin
N/A
Profit Margin
14.91%
Returns and Earnings
Return on Assets (TTM)
0.82%
Return on Equity (TTM)
1.11%
EBITDA
€267.5M
Net Income (TTM)
€7.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€4.01
Quarterly Revenue Growth (YoY)
22.39%
Quarterly Earnings Growth (YoY)
103.99%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| -3x Short ARK SARKK | N/A Micro-cap | -17.64% | -30.44% | 31,775.00% | 7,868.75% | 6,610.53% | 3,255.26% | 83.45% | 21.43% |
| UBS AG, London 0022U | N/A Micro-cap | 0.09% | 0.47% | 3.30% | 3.04% | 3.93% | 8.73% | 24.56% | 24.56% |
| GLDFP 100PRO0825U 0110U | N/A Micro-cap | 0.08% | 0.35% | 1.16% | 2.41% | 2.94% | 6.55% | 22.72% | 22.72% |
| MSCIW 103PRO0226U 0119U | N/A Micro-cap | -0.02% | -0.02% | 1.62% | 3.24% | 4.61% | 6.94% | 19.67% | 19.67% |
| Ark Genomic 1ARKG | N/A Micro-cap | 8.94% | 11.43% | 16.77% | 6.56% | -1.02% | 3.72% | -96.66% | -96.93% |
| 1Ark Innovation 1ARKK | N/A Micro-cap | 6.57% | 10.36% | 20.32% | 44.57% | 28.62% | 68.78% | 49.20% | 153.74% |
Ownership & Short Interest
Insider Ownership
N/A
Institutional Ownership
N/A
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
8
Average 90-Day Volume
46
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SARKK's 52-week high and low?
- In the last 52 weeks, -3x Short ARK reached a high of €25.70 (on July 8, 2025) and a low of €0.03 (on July 7, 2025).
- What is the market cap and P/E ratio for SARKK?
- Curious about -3x Short ARK's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is 497.20, and the forward P/E (looking ahead) is N/A.
- Does SARKK pay dividends? If so, what's the yield?
- As for dividends, -3x Short ARK isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are -3x Short ARK's main competitors or similar companies to consider before investing?
When looking at -3x Short ARK, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UBS AG, London
0022UN/A N/A N/A 8.73% 24.56% GLDFP 100PRO0825U
0110UN/A N/A N/A 6.55% 22.72% MSCIW 103PRO0226U
0119UN/A N/A N/A 6.94% 19.67% Ark Genomic
1ARKGN/A N/A N/A 3.72% -96.66% 1Ark Innovation
1ARKKN/A N/A N/A 68.78% 49.20% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for -3x Short ARK Innovation ETP? (e.g., ROE, Debt/Equity)
- To get a sense of -3x Short ARK's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.11%, the Debt to Equity ratio from the most recent quarter is 0.03, and its Gross Profit Margin stands at 28.04%.
- What is the recent revenue and earnings growth for SARKK?
- Looking at -3x Short ARK's growth, its revenue over the trailing twelve months (TTM) was €865M. Compared to the same quarter last year (YoY), quarterly revenue grew by 22.39%, and quarterly earnings saw a YoY growth of 103.99%.
- How much of SARKK stock is held by insiders and institutions?
- Wondering who owns -3x Short ARK stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.